Is the Fixed-Dose Intravenous Trastuzumab Policy Warranted in Limited-Resource Settings?

J Glob Oncol. 2019 Jan:5:1-3. doi: 10.1200/JGO.18.00155.

Authors

Loay Kassem¹, Kyrillus S Shohdy¹, Ahmad M Abdel-Azeez², Hanaa Attia¹

Affiliations

¹ Cairo University Kasr Alainy Faculty of Medicine, Cairo, Egypt.
² Minia University, Minia, Egypt.

No abstract available

MeSH terms

Administration, Intravenous
Adult
Aged
Antineoplastic Agents, Immunological / administration & dosage*
Breast Neoplasms / drug therapy*
Breast Neoplasms / economics
Breast Neoplasms / enzymology
Developing Countries
Drug Dosage Calculations
Egypt
Female
Health Resources / economics*
Humans
Middle Aged
Receptor, ErbB-2 / antagonists & inhibitors
Receptor, ErbB-2 / metabolism
Trastuzumab / administration & dosage*
Young Adult

Substances

Antineoplastic Agents, Immunological
ERBB2 protein, human
Receptor, ErbB-2
Trastuzumab